Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 53

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 53
---
 may make the acquisition of the Company more difficult, including the following:

| ● | our stockholders will only                                                                                                            
 be able to take action at a meeting of stockholders and will not be able to take action by written consent for any matter;            |
| ● | our board of directors                                                                                                                
 is classified into three classes of directors with staggered three-year terms;                                                        |
| ● | a special meeting of our                                                                                                              
 stockholders may only be called by a majority of our board of directors;                                                              |
| ● | advance notice procedures                                                                                                             
 apply for stockholders to nominate candidates for election as directors or to bring matters before an annual meeting of stockholders; 
 and                                                                                                                                   |
| ● | certain litigation against                                                                                                            
 us can only be brought in Nevada.                                                                                                     |

These provisions, alone
or together, could discourage, delay or prevent a transaction involving a change in control of the Company. These provisions could also
discourage proxy contests and make it more difficult for stockholders to elect directors of their choosing and to cause us to take other
corporate actions they desire, any of which, under certain circumstances, could limit the opportunity for our stockholders to receive
a premium for their shares of our Common Stock, and could also affect the price that some investors are willing to pay for our Common
Stock.

We may be subject to securities litigation, which is expensive and could divert management attention.

In the past, companies
that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be
the target of this type of litigation in the future. Litigation of this type could result in substantial costs and diversion of management’s
attention and resources, which could seriously hurt our business. Any adverse determination in litigation could also subject us to significant
liabilities.

FINRA sales practice requirements may limit a stockholder’s ability to buy and sell our stock.

The Financial Industry Regulatory Authority (“FINRA”)
has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing
that the investment is suitable for that customer. Prior to recommending speculative low-priced securities to their non-institutional
customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status,
investment objectives and other information. Under interpretations of these rules, the FINRA believes that there is a high probability
that speculative low-priced securities will not be suitable for at least some customers. The FINRA requirements